Globus Medical, Inc.
GMED Healthcare Medical Devices
Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024.
- Revenue
- −0.69%
- EPS
- +19.3%
- Free cash flow
- +10.1%
Quarter to September 2026, against a year earlier
Follow GMED
Alert me
Globus Medical, Inc. (GMED) Book value per share
Globus Medical, Inc.'s book value per share at the end of fiscal 2025 was 33.8×, up 9.89% from 30.8× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 35.8×. Over the past ten years it has ranged from 7.5× (fiscal 2015) to 35.4× (fiscal 2023); the current reading is higher than 91% of that period. Globus Medical, Inc. ranks 11th of 149 Medical Devices companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 33.8× | 9.89% |
| FY2024 | 30.8× | (12.94%) |
| FY2023 | 35.4× | 92.37% |
| FY2022 | 18.4× | 6.31% |
| FY2021 | 17.3× | 13.14% |
| FY2020 | 15.3× | 8.02% |
| FY2019 | 14.1× | 16.79% |
| FY2018 | 12.1× | 20.44% |
| FY2017 | 10.1× | 15.59% |
| FY2016 | 8.7× | 15.59% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 35.8× | 1.26% |
| Jun 2026 | 35.3× | 1.00% |
| Mar 2026 | 35.0× | 3.36% |
| Dec 2025 | 33.8× | 3.42% |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| BIO.B Bio-Rad Laboratories, Inc. compare | 284× |
| BIO Bio-Rad Laboratories, Inc. compare | 284× |
| PEN Penumbra, Inc. compare | 40.2× |
| GMED Globus Medical, Inc. | 35.8× |
| PODD Insulet Corporation compare | 22.8× |
| BRKR Bruker Corporation compare | 15.1× |
| GKOS Glaukos Corporation compare | 12.1× |
| TXG 10x Genomics compare | 6.4× |
| SNN Smith & Nephew SNATS, Inc. compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on GMED
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement